Viomerse
PrivateLast Round
Grant
Aug 15, 2021
Total Funding Raised
$730,395
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Viomerse operates in Healthcare & Life Sciences and is based in Pittsford, New York. Its latest recorded funding round was a Grant round in August 2021.
Viomerse is a healthtech company that develops high-fidelity surgical training phantoms and an extended reality remote training platform to provide immersive, risk-free surgical education.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials, AR/VR Experiences, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Viomerse Comparables
Compare Viomerse with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Inovus Medical | 86% | |
| SurgeonsLab AG | 85% | |
| VirtaMed | 81% |
For institutional investors. Book with your work email.
Viomerse Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 15, 2021 | ||||
| Accelerator | Nov 7, 2019 | ||||
| Grant | Jun 18, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Viomerse Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Luminate Accelerator | Accelerator |
| National Institutes of Health (NIH) | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 43% MoM.
- May 15, 2026
Monthly visitors grew 310% MoM, reaching 1K.
For institutional investors. Book with your work email.
Viomerse Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Viomerse's valuation, stock price, and market status.
Is Viomerse a public or private company?
Viomerse is a private company.
What is the current stock price of Viomerse?
Viomerse is a private company, so its shares have no public market price. Caplight tracks Viomerse's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Viomerse worth (valuation)?
Valuation information for Viomerse is not publicly available.
Can I buy Viomerse stock?
Viomerse shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Viomerse's last funding round?
Viomerse's most recent funding round was Grant on August 15, 2021.
Who are the main investors in Viomerse?
Key investors in Viomerse include Luminate Accelerator, National Institutes of Health (NIH), National Science Foundation.
Will Viomerse IPO soon?
No public IPO plans have been announced for Viomerse.
How can I track Viomerse secondary market activity?
Caplight tracks bids, offers, and trades in Viomerse's shares on secondary markets.